156 related articles for article (PubMed ID: 29218466)
1. Acute herpes zoster and post herpetic neuralgia in primary care: a study of diagnosis, treatment and cost.
Crosbie B; Lucey S; Tilson L; Domegan L; Kieran J
Eur J Clin Microbiol Infect Dis; 2018 Apr; 37(4):627-631. PubMed ID: 29218466
[TBL] [Abstract][Full Text] [Related]
2. Herpes zoster and postherpetic neuralgia in Catalonia (Spain).
Salleras L; Salleras M; Salvador P; Soldevila N; Prat A; Garrido P; Domínguez A
Hum Vaccin Immunother; 2015; 11(1):178-84. PubMed ID: 25483532
[TBL] [Abstract][Full Text] [Related]
3. Burden of herpes zoster and post-herpetic neuralgia in Sweden.
Nilsson J; Cassel T; Lindquist L
BMC Infect Dis; 2015 May; 15():215. PubMed ID: 26002038
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology and economic burden of herpes zoster and post-herpetic neuralgia in Italy: a retrospective, population-based study.
Gialloreti LE; Merito M; Pezzotti P; Naldi L; Gatti A; Beillat M; Serradell L; di Marzo R; Volpi A
BMC Infect Dis; 2010 Aug; 10():230. PubMed ID: 20682044
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology and cost of herpes zoster and post-herpetic neuralgia in the United Kingdom.
Gauthier A; Breuer J; Carrington D; Martin M; Rémy V
Epidemiol Infect; 2009 Jan; 137(1):38-47. PubMed ID: 18466661
[TBL] [Abstract][Full Text] [Related]
6. Measuring the burden of herpes zoster and post herpetic neuralgia within primary care in rural Crete, Greece.
Lionis CD; Vardavas CI; Symvoulakis EK; Papadakaki MG; Anastasiou FS; Antonopoulou MD; Apostolakis CM; Dimitrakopoulos SA; Fountakis GI; Grammatikopoulos IA; Komninos JD; Kounalakis DK; Ladoukaki ES; Makri KV; Petraki CS; Ploumis NG; Prokopiadou DP; Stefanaki IN; Tsakountakis NA; Tsiligianni IG; Tzortzis EN; Vasilaki AA; Vasilopoulos TK; Vrentzos GE
BMC Fam Pract; 2011 Dec; 12():136. PubMed ID: 22145678
[TBL] [Abstract][Full Text] [Related]
7. Treatment patterns of postherpetic neuralgia patients before and after the launch of pregabalin and its effect on medical costs: Analysis of Japanese claims data provided by Japan Medical Data Center.
Honda M; Murata T; Ebata N; Fujii K; Ogawa S
J Dermatol; 2017 Jul; 44(7):767-773. PubMed ID: 28256737
[TBL] [Abstract][Full Text] [Related]
8. Diagnosing and managing postherpetic neuralgia.
Nalamachu S; Morley-Forster P
Drugs Aging; 2012 Nov; 29(11):863-9. PubMed ID: 23038608
[TBL] [Abstract][Full Text] [Related]
9. Current management of herpes zoster: the European view.
Volpi A; Gross G; Hercogova J; Johnson RW
Am J Clin Dermatol; 2005; 6(5):317-25. PubMed ID: 16252931
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology and cost of herpes zoster and postherpetic neuralgia among patients treated in primary care centres in the Valencian community of Spain.
Cebrián-Cuenca AM; Díez-Domingo J; San-Martín-Rodríguez M; Puig-Barberá J; Navarro-Pérez J;
BMC Infect Dis; 2011 Nov; 11():302. PubMed ID: 22044665
[TBL] [Abstract][Full Text] [Related]
11. Herpes zoster: diagnostic, therapeutic, and preventive approaches.
Bader MS
Postgrad Med; 2013 Sep; 125(5):78-91. PubMed ID: 24113666
[TBL] [Abstract][Full Text] [Related]
12. Cost of shingles: population based burden of disease analysis of herpes zoster and postherpetic neuralgia.
Friesen KJ; Chateau D; Falk J; Alessi-Severini S; Bugden S
BMC Infect Dis; 2017 Jan; 17(1):69. PubMed ID: 28086817
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.
Pellissier JM; Brisson M; Levin MJ
Vaccine; 2007 Nov; 25(49):8326-37. PubMed ID: 17980938
[TBL] [Abstract][Full Text] [Related]
14. Herpes zoster and postherpetic neuralgia: prevention and management.
Fashner J; Bell AL
Am Fam Physician; 2011 Jun; 83(12):1432-7. PubMed ID: 21671543
[TBL] [Abstract][Full Text] [Related]
15. Economic Burden of Herpes Zoster ("culebrilla") in Latin America.
Rampakakis E; Pollock C; Vujacich C; Toniolo Neto J; Ortiz Covarrubias A; Monsanto H; Johnson KD
Int J Infect Dis; 2017 May; 58():22-26. PubMed ID: 28267595
[TBL] [Abstract][Full Text] [Related]
16. [Herpes zoster in old adults].
Lang PO; Belmin J; Michel JP
Presse Med; 2009 Apr; 38(4):571-83. PubMed ID: 19028069
[TBL] [Abstract][Full Text] [Related]
17. [Burden of herpes zoster and postherpetic neuralgia: Incidence, proportion, and associated costs in the French population aged 50 or over].
Mick G; Gallais JL; Simon F; Pinchinat S; Bloch K; Beillat M; Serradell L; Derrough T
Rev Epidemiol Sante Publique; 2010 Dec; 58(6):393-401. PubMed ID: 21094001
[TBL] [Abstract][Full Text] [Related]
18. Antiviral therapies for herpes zoster infections. Are they economically justifiable?
Smith KJ; Roberts MS
Pharmacoeconomics; 2000 Aug; 18(2):95-104. PubMed ID: 11067653
[TBL] [Abstract][Full Text] [Related]
19. Burden of disease from shingles and post-herpetic neuralgia in the over 80 year olds in the UK.
Matthews I; Duong M; Parsons VL; Nozad B; Qizilbash N; Patel Y; Guimicheva B
PLoS One; 2020; 15(2):e0229224. PubMed ID: 32097441
[TBL] [Abstract][Full Text] [Related]
20. Use of S-LANSS, a tool for screening neuropathic pain, for predicting postherpetic neuralgia in patients after acute herpes zoster events: a single-center, 12-month, prospective cohort study.
Cho SI; Lee CH; Park GH; Park CW; Kim HO
J Pain; 2014 Feb; 15(2):149-56. PubMed ID: 24342706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
